Lipolysis by human adipose tissue: the role of cyclic 3',5'-adenosine monophosphate and adrenergic receptor sites.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D002628:Chemoreceptor Cells / Q000187:drug effects; D000242:Cyclic AMP; D004837:Epinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D007545:Isoproterenol / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D050356:Lipid Metabolism; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D002087:Butyrates; D007328:Insulin; D011453:Prostaglandins; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine